Choreo LLC bought a new stake in Celestica Inc. (NYSE:CLS – Free Report) (TSE:CLS) in the 4th quarter, HoldingsChannel ...

Celestica Inc. (NYSE:CLS – Get Free Report) (TSE:CLS) shares were up 1.7% during mid-day trading on Thursday after Barclays raised their price target on the stock from $139.00 to $157.00. Barclays ...

Given their solid financials and healthy growth prospects, these two Canadian stocks could be excellent buys. The post Top ...

The supposed secrets of TFSA millionaires are out in the open; just follow them and be one, too. The post 4 Secrets of TFSA ...

There were plenty of stock market surprises in 2024. Here are two Canadian stocks that surprised to the downside and one to ...

Its high growth potential, resilience to the emergence of low-cost LLMs, and low valuation make it a compelling stock in the ...

Barclays raised the firm’s price target on Celestica (CLS) to $157 from $139 and keeps an Overweight rating on the shares after meeting with ...

Brinker International, Business First Bancshares, AZEK, Celestica and Boston Scientific have been highlighted in this Screen ...

In a report released today, George Wang CFA from Barclays maintained a Buy rating on Celestica (CLS – Research Report), with a price target of ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 23 tables and 54 figures, this 108 page report North America Medical Device Contract Manufacturing Market 2021-2031 by ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 82 tables and 90 figures, this 169 page report Global Medical Device Contract Manufacturing Market 2021-2031 by Device ...

CLS is well poised for sustained growth backed by robust infrastructure investments, solid technology know-how and wide industry experience.